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pIX modiﬁcationIX (pIX) has been shown to be a potential locale to insert targeting, imaging-
related and therapeutic modalities by genetic modiﬁcation. Recent evidences suggested that capsid protein
mosaicism could be a promising strategy for improving the utility of Ad vector. In this study, we explored a
method to genetically generate triple pIX mosaic Ad serotype 5 (Ad5) displaying three types of pIX on a single
virion. pIXs were modiﬁed at their carboxy termini with a Flag sequence, a hexahistidine sequence (His6) or a
monomeric red ﬂuorescent protein (mRFP1), respectively. Western blotting analysis and ﬂuorescence
microscopy of the puriﬁed recombinant viruses indicated that all three modiﬁed pIXs were incorporated into
the viral particles. Immuno-gold electron microscopy (EM) further conﬁrmed that three types of pIX indeed
co-existed on an individual virion. These results ﬁrstly validated a triple mosaic capsid conﬁguration on pIX,
and demonstrated the possibility of further radical design.
Published by Elsevier Inc.IntroductionAdenovirus (Ad) is about 70–100 nm in size, non-enveloped ico-
sahedral virus with a capsid of 252 capsomers: 240 hexons forming
the faces and 12 pentons at the vertices, each of which bears a slender
ﬁber (Doerﬂer, 1996). Ad genome is linear, non-segmented double
stranded DNAwith a length of 30–36 kb. Ad vectors have been utilized
as a basic tool for gene delivery in a variety of studies, and account for
one fourth total number of gene therapy clinical trials worldwide thus
far (http://www.wiley.com/legacy/wiley-chi/genmed/clinical/). The
broad usage of Ad is attributable to its ability to infect a wide range
of cell types, high efﬁciency of gene transfer, ability to incorporate
large DNA inserts into its genome, and also efﬁcient methods available
for generation of recombinant viruses. In regard to the most com-
monly used Ad serotypes for gene delivery, Ad2 and Ad5 from sub-
group C, binding of the globular knob domain of the Ad ﬁber protein
with primary cellular receptor, coxsackievirus group B and adenovirus
receptor (CAR), has been identiﬁed as the initial step of infection in
in vitro studies (Bergelson et al., 1997; Roelvink et al., 1998; Tomko
et al., 1997). After administrated in mice, monkeys and pigs as a viral
vector, wild type Ad or tropism unaltered recombinant Ad is mainly
distributed in the liver, lung and spleen (Breidenbach et al., 2004;
Torres et al., 1996; Xin et al., 2005); however, the distribution is highlyhology Service, 55 Fruit Street -
nc.dependent on animal species and administration methods, e.g. intra-
muscularly, intravenously or intraperitoneally.
To fulﬁll gene delivery to CAR-deﬁcient cell types and circumvent
host neutralization of Ad vectors, modiﬁcation on capsid proteins has
been explored by genetically incorporating peptide ligands on ﬁber,
penton base and hexon (Dmitriev et al., 1998; Roy et al., 1998; Vigne
et al., 1999; Wickham et al., 1996a,b; Wu et al., 2002). However, major
capsid proteins are crucial for Ad assembly and stability, and their
structural properties only allow for incorporation of constrained he-
terologous ligands, which apparently have size limitationwhen added
to the C terminus and HI loop of ﬁber (Belousova et al., 2002;Wickham
et al., 1997) and hexon L1 loop (Matthews et al., unpublished data).
pIX is expressed at delayed early stage with a molecular weight of
14.3 kDa, and is a minor capsid protein associated with group-of-nine
(GONs), acting as a stabilizing cement via its N-terminal domain
interaction (Furcinitti et al., 1989; Parks, 2005; Rosa-Calatrava et al.,
2001; Vellinga et al., 2005). pIX is considered not required for virus
assembly (Colby and Shenk, 1981); however, it is essential for ther-
mostability and packaging of full length genomes (Ghosh-Choudhury
et al., 1987). Recent Cryo-EM data (Marsh et al., 2006; Saban et al.,
2005, 2006), structural and functional studies of pIX (Akalu et al.,1999;
Rosa-Calatrava et al., 2001) suggested a theoretical possibility that the
C terminus of pIX, which either binds on the capsid surface or extends
outward from the capsid, can tolerate considerable modiﬁcation and
be utilized as an anchor for the addition of heterologous ligands to Ad
particles. This thoughtwas further demonstrated by several studies on
Ad tropism alteration (Dmitriev et al., 2002; Vellinga et al., 2007;
Zakhartchouk et al., 2004), in vivo imaging and tracking of physical Ad
Fig. 1. Schema of Ad pIX modiﬁcation. (A) Structural diagram of Ad5 vector with triple modiﬁcations. Flag, His6 polypeptides and mRFP1 protein were incorporated in the C terminus
of pIX. (B) Constructs of modiﬁed pIX genes in genomes of Ad5IXmRFP1, Ad5-IXFlag-IXmRFP1 and Ad5-IXFlag-IXHis6-IXmRFP1. IX-Flag and IX-His6 were driven by CMV and SV40
promoter, respectively, and inserted in Ad E1 region. “En” stands for SV40 enhancer. IX-mRFP1 was located at native region of pIX gene, driven by its native promoter (not shown
here). (C) Amino acid residues of Flag and His6 polypeptides and mRFP1 protein (incomplete) that were incorporated into the C terminus of pIX.
Fig. 2. Western blotting analysis of Ad vector containing triple pIX modiﬁcations. 1010
VPs of CsCl-puriﬁed Ad5-IXFlag-IXHis6-IXmRFP1 were subjected to SDS-PAGE. The
separated proteins were probed with rabbit anti-pIX (lane 1), mouse anti-His6 (lane 2)
or mouse anti-Flag (lane 3) antibody, and developed with AP-conjugated goat anti-
mouse or anti-rabbit secondary antibodies. IX-mRFP1 contains a Flag peptide in the C
terminus of pIX when originally constructed (Le et al., 2006). The number on the left
indicated the molecular mass in daltons. The (⁎) symbol was a non-speciﬁc band.
392 Y. Tang et al. / Virology 377 (2008) 391–400particles (Le et al., 2004, 2006; Meulenbroek et al., 2004) and cancer
therapeutics (Li et al., 2005) via genetically incorporating correspond-
ing heterologous polypeptides on pIX C terminus.
Therefore, pIX is an attractive candidate for the placement of
functional motifs, and based on previous studies of pIX modiﬁcation,
we hypothesize that pIX may be utilized as a locale to accommodate
multiple functional motifs on a single virion. To test this hypothesis,
we attempted to incorporate three types of pIX into a single virion via
genetic modiﬁcation. We created a recombinant type 5 Ad carrying
three types of genetically modiﬁed pIXs, each of which contained a
distinct tag at its C terminus. Using Western Blotting analysis and
immunogold labeling electron microscopy, we demonstrated that
three types of pIX were incorporated into the virus and could coexist
on a single virion. This is, to our knowledge, the ﬁrst derived triple
mosaic Ad, suggesting the possibility of further radical capsid design
for simultaneously employing multiple functional modalities.
Results
Generation of genetically pIX-modiﬁed Ad5 vectors
Since pIXhas been shown to be an incorporation site of heterologous
polypeptide ligands on human adenovirus (Ad) capsid without
perturbation of viral viability, capsid stability or loss of peptide func-
tionality (Dmitriev et al., 2002; Le et al., 2004, 2006; Matthews et al.,
2006; Vellinga et al., 2004), it is possible that multiple pIXs carrying
different ligands can be incorporated and presented in a single virion. To
investigate this possibility, and test whether three types of pIXs can be
efﬁciently incorporated into Ad, we constructed E1/E3-deleted Ad5
vector carrying three modiﬁed pIX genes containing Flag, hexahistidine
(His6) ormonomeric red ﬂuorescent protein (mRFP1) sequences at their
3′ ends immediately before the stop codons. To minimize internal ho-
mologous recombination among modiﬁed pIX genes, we employed
human cytomegalovirus (CMV) immediate-early promoter to drive IX-Flag gene expression and simian virus 40 (SV40) early promoter to
drive IX-His6 gene expression, respectively. These two pIX-expres-
sion cassettes were inserted upstream of the IX-mRFP1 gene driven
by the native pIX promoter, resulting in an Ad plasmid carrying three
modiﬁed pIX genes (Fig. 1B). Meanwhile an Ad plasmid containing
only two pIX genes (IX-Flag and IX-mRFP1) was created for the
purpose of comparison. These two Ad plasmids, pAd5-IXFlag-
IXmRFP1 and pAd5-IXFlag-IXHis6-IXmRFP1, were transfected into
293 cells to generate pIX-modiﬁed viruses, Ad5-IXFlag-IXmRFP1 and
Ad5-IXFlag-IXHis6-IXmRFP1. These two viruses were successfully
rescued and their genomic structures were veriﬁed by restriction
enzyme digestion. An Ad5IXmRFP1 virus containing a single modi-
ﬁcation of C-terminal mRFP1 in pIX (Le et al., 2006) was used as a
control and its construct was shown in Fig. 1B.
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Western blotting analysis was used to conﬁrm the incorporation of
three heterologous pIXs into viral capsid. The CsCl-puriﬁed viral
particles of Ad5-IXFlag-IXHis6-IXmRFP1 were denatured by boiling
and the capsid proteins were dissolved by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). The probing of sepa-
rated viral proteins of Ad5-IXFlag-IXHis6-IXmRFP1 using mouse anti-
Flag, anti-His6 antibodies and a rabbit anti-pIX antibody detected the
presence of protein bandswithmolecularweights of 15 kDa, 21 kDa, and
50 kDa, corresponding to IX-His6, IX-Flag, and IX-mRFP1 fusionproteins,
respectively (Fig. 2). The presence of IX-mRFP1 protein was further
conﬁrmed by ﬂuorescence microscopy on intact viral particles. Puriﬁed
virions were directly visualized under a ﬂuorescence microscope to
detect the red ﬂuorescent signal of mRFP1 protein, and Ad5IXmRFP1,
Ad5-IXFlag-IXmRFP1, and Ad5-IXFlag-IXHis6-IXmRFP1 viruses were
demonstrated to contain mRFP1 protein in viral capsid (Fig. 3). Of
note, two mosaic viruses (Ad5-IXFlag-IXmRFP1 and Ad5-IXFlag-IXHis6-
IXmRFP1 in panel C and D, respectively) had less ﬂuorescent signal
compared to single pIX-modiﬁed virus (Ad5IXmRFP1 in panel B), in-
dicating that the incorporation levels of IX-mRFP1 fusion protein were
lower in the two mosaic viruses.
Presentation of modiﬁed pIX on virion capsid
To test whether or not the polypeptides incorporated into the C
terminus of pIX were presented on viral surface and accessible to their
speciﬁc antibodies, we performed enzyme-linked immunosorbent
assays (ELISAs) in which mouse anti-Flag, anti-His6 antibodies and
rabbit anti-RFP antibodies were used to detect three modiﬁed pIXs,
respectively. The control Ad5 containing wild type pIXs was not re-
cognized by any of these antibodies. The anti-Flag antibody recog-
nized all three pIX-modiﬁed Ads since Flag tag was contained in IX-
Flag and IX-mRFP1 fusion proteins. Ad5IXmRFP1 showed the highest
level of interaction with anti-Flag antibody, and Ad5-IXFlag-IXmRFP1Fig. 3. Direct visualization of pIX-modiﬁed Ad vector by ﬂuorescence microscopy. 5×109
ﬂuorescence microscope with a ×100 objective using oil immersion. (A) Control Ad5 with wil
The thick arrows indicate heavily aggregated viral particles and the narrow arrows indicatehad slightly weak interaction, while Ad5-IXFlag-IXHis6-IXmRFP1 had
the lowest binding (Fig. 4A). The anti-His6 antibodymoderately bound
to Ad5-IXFlag-IXHis6-IXmRFP1 (Fig. 4B). These results demonstrated
that Flag, His6 epitopes introduced into the pIX C termini were dis-
played on the surfaces of these pIX-modiﬁed Ads and accessible for
recognition by antibodies. However, anti-RFP antibody did not bind
Ad5-IXFlag-IXmRFP1 and Ad5-IXFlag-IXHis6-IXmRFP1 as revealed by
Fig. 4C, while efﬁciently bound to Ad5IXmRFP1. This could be due to
that mRFP1 were masked by other epitopes (e.g Flag or His6) in the
heterotrimeric pIX protein, or the low incorporation rate of IX-mRFP1
proteins in Ad5-IXFlag-IXmRFP1 and Ad5-IXFlag-IXHis6-IXmRFP1,
which was under the limit of the ELISA detection.
CAR-dependent binding of pIX-modiﬁed adenovirus
Adenovirus has been shown to bind its primary cellular receptor
CAR as the initial step of infection via its ﬁber knob protein. To examine
whether the modiﬁcation of pIX in Ad capsid interferes with the
interaction, we performed the binding assay in 293 cells in the pre-
sence or absence of soluble CAR (sCAR) protein, which was used as
competitive inhibitors. Thepresence of sCAR (200 μg/ml) blockedN90%
cell binding of Ad5, Ad5IXmRFP1 and Ad5-IXFlag-IXHis6-IXmRFP1,
N70% of Ad5-IXFlag-IXmRFP1 (Fig. 5A), indicating that the cell binding
of all pIX-modiﬁed Ad5 is still CAR-dependent.
Infectivity of pIX-modiﬁed Ad5 vectors
Since capsid modiﬁcation may affect the native infectivity of Ad5,
we carried out infection assay in four CAR positive cell lines: 293,
A549, GH329 and HeLa. Because there is no appropriate reporter gene
in the pIX-modiﬁed Ads, we could not perform traditional infectivity
assay based on transgene expression, e.g. luciferase activity. None-
theless, we attempted to use the total viral genomes transferred into
cells following 2-hour incubation as an assessment of infectivity. After
infection, the cells were harvested by trypsin/EDTA and the total DNAVPs of CsCl-puriﬁed Ad were mounted on a microscope slide and examined under a
d type pIX; (B) Ad5IXmRFP1; (C) Ad5-IXFlag-IXmRFP1; (D) Ad5-IXFlag-IXHis6-IXmRFP1.
slightly aggregated or single viral particles.
Fig. 4. Presentation of modiﬁed IX proteins on Ad capsid surface. (A) 109 VPs of CsCl-
puriﬁed Ad5IXmRFP1, Ad5-IXFlag-IXmRFP1, and Ad5-IXFlag-IXHis6-IXmRFP1 virus
(designated as “Single”, “Double” or “Triple” in the ﬁgure, respectively) were subjected
to a serial dilution (1, 2, 4, 8, 16, 32, 64, and 128) and immobilized on an ELISA plate.
Then the viruses were probed with mouse anti-Flag (A), mouse anti-His6 (B) and rabbit
anti-RFP (C) antibodies, which were further detected using alkaline phosphatase-
conjugated goat anti-mouse or anti-rabbit secondary antibody. Wild type Ad5 was used
as a negative control. Each point represents the mean and standard deviation (SD) of
triplicate determinations. Some error bars standing for SDs are smaller than their
symbols.
Fig. 5. Cell Binding and infectivity of pIX-modiﬁed Ads. (A) CAR Binding inhibition assay.
293 cells were incubated with Ad5, Ad5IXmRFP1, Ad5-IXFlag-IXmRFP1 and Ad5-IXFlag-
IXHis6-IXmRFP1 (designated as “Single”, “Double” or “Triple” in the ﬁgure, respectively)
at an MOI equivalent to 1000 VP/cell in the presence of 200 μg/ml sCAR protein at 4 °C.
After 2 h, total DNA was extracted from cells and Ad5 genome copy numbers were
determined by quantitative real-time PCR (Q-PCR). Values represent the relative
amounts of Q-PCR readings and are expressed as percentage of cell binding relative to
the corresponding control virus without adding sCAR protein (white bars). (B) pIX-
modiﬁed Admediated genome transfer. 293, A549, GH329 and HeLa cells were infected
with Ad5, Ad5IXmRFP1, Ad5-IXFlag-IXmRFP1 and Ad5-IXFlag-IXHis6-IXmRFP1 at an
MOI of 100 VP/cell at 37 °C. Total DNAwere extracted from virus infected cells after 2 h,
Ad genome copy numbers were determined by Q-PCR and plotted on the Y-coordinate.
Each bar represents themean and SD of triplicate determinations, and asterisks indicate
signiﬁcant difference of infectivity between pIX-modiﬁed Ads and control Ad5. The
actual measurements in 293 and HeLa cells were showed above the bars.
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ber by quantitative real-time PCR (Q-PCR). All pIX-modiﬁed viruses
exhibited similar infectivity and showed no signiﬁcant difference
among each other (Fig. 5B). In A549 and GH329 cells, pIX-modiﬁed
viruses showed comparable infectivity with control Ad5; nevertheless
in 293 and HeLa cells, infectivity of pIX-modiﬁed viruses was appro-
ximately one half of the control Ad5.
Thermostability of pIX-modiﬁed Ads
pIX is a cement protein and stabilizes Ad capsid. This raised a
question thatwhether themodiﬁcation onpIX could affect the stability
and structure integrity of the viral particle. Thus we compared the
thermostabilities of pIX-modiﬁed Ads to that of control Ad5 with wild
type pIX. CsCl-puriﬁed viruses were incubated at 45 °C for various
time, followed by re-titration using TCID50. All pIX-modiﬁed viruses
exhibited compromised stability to some extent compared to control
Ad5 when exposed at 45 °C for various time (Figs. 6A and B). Sp-
eciﬁcally, after 40-min incubation, the remaining titer of Ad5IXmRFP1,
which contains single pIX modiﬁcation, was slightly reduced com-pared to control Ad5 when incubated in medium (P=0.053), but
severely reduced when incubated in PBS (P=0.017). The remaining
titer of Ad5-IXFlag-IXmRFP1,which contains double pIXmodiﬁcations,
was severely reduced when incubated in medium (P=0.049) and in
PBS (P=0.016). The remaining titer of Ad5-IXFlag-IXHis6-IXmRFP1,
which contains triple pIX modiﬁcations, was slightly reduced when
incubated inmedium (P=0.081) and in PBS (P=0.13). The results shows
that the thermostability of pIX-modiﬁedAd5was compromised,which
was consistent with an increased VP/PFU ratio observed in pIX-
modiﬁed viruses (98, 387, 391, and 245 for control Ad5, single, double,
and triple pIX-modiﬁed Ad5, respectively).
Growth kinetics of pIX-modiﬁed Ad5
During the generation of Ad5-IXFlag-IXmRFP1 and Ad5-IXFlag-
IXHis6-IXmRFP1, we noticed that it took longer for transfected 293
cells to induce complete CPE compared with unmodiﬁed Ad5 (data
not shown), indicating that themodiﬁcation on pIXwas likely to affect
virus packaging. To obtain a quantitative understanding of this effect,
growth kinetics of the pIX-modiﬁed viruses were studied and
compared with that of wild type Ad5. Fig. 6C showed that wild type
control Ad5 induced a full CPE and produced a maximumyield of viral
progeny 3 days post infection; however, even though all pIX-modiﬁed
Fig. 6. Thermostability and growth kinetics of pIX-modiﬁed Ads. (A) Heat inactivation of
viral particles. CsCl-puriﬁed Ad5, Ad5IXmRFP1, Ad5-IXFlag-IXmRFP1 and Ad5-IXFlag-
IXHis6-IXmRFP1 viruses (designated as “Single”, “Double” or “Triple” in the ﬁgure) were
incubated in growth media or in PBS at 45 °C. After various time points post infection,
the viral infectious titers were re-determined by TCID50 assay. Each point represents the
mean and SD of duplicate determinations. (B) Growth Kinetics of Ads in 293 cells. 293
cells were infected with Ad5, Ad5IXmRFP1, Ad5-IXFlag-IXmRFP1 and Ad5-IXFlag-
IXHis6-IXmRFP1 viruses at an MOI of 5 VP/cell. Cells were harvested with medium at
different time points until full CPE was induced, and total viruses were determined by
TCID50 assay and plotted on the diagram as growth curves. Each point represents the
mean and SD of duplicate determinations.
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took 8 days to completely induce CPE with the yield of 2 log mag-
nitudes lower than that of control Ad5 approximately. These data
implied that the modiﬁcation on pIX had an adverse effect on Ad's
packaging resulting in more defective viral particles in population, or
the modiﬁcation downregulated viral protein synthesis.
Immunoelectron microscopy
Using Western blotting analysis on puriﬁed viral particles, we have
demonstrated that three types of modiﬁed pIXs were incorporated into
the Ad5-IXFlag-IXHis6-IXmRFP1 capsids. However, it is possible that
three types of pIXs were not incorporated into one single virion and
those modiﬁed IX proteins came from different viral populations. To
examine whether a single virion could display all three types of pIX, we
performed immunogold electron microscopy to directly visualize pIX-
modiﬁed Ads. Mouse anti-Flag, goat anti-His6 and rabbit anti-RFP
antibodieswere used to detect IX-Flag, IX-His6 and IX-mRFP1 proteins inviral capsids, followedby three secondaryantibodies conjugatedwith10,
18, and 25 nm gold particles, respectively. Control Ad5 displaying wild
type pIX did not bind any antibody as shown in Fig. 7A. The Ads con-
taining single pIXmodiﬁcation (Ad5IXFlag, Ad5IXHis6 andAd5IXmRFP1)
were recognized by corresponding primary and secondary antibodies
(Figs. 7, B–D). The Ad containing double pIX modiﬁcations (Ad5-IXFlag-
IXmRFP1) was recognized by anti-Flag and anti-RFP antibodies, and
labeled with 10 and 25 nm gold particles (Fig. 7E). The Ad containing
triple pIX modiﬁcations (Ad5-IXFlag-IXHis6-IXmRFP1) was recognized
by anti-Flag, anti-His6 and anti-RFP antibodies and labeled with 10, 18
and 25 nm gold particles as shown in Fig. 7F. The results showed that
three types of modiﬁed pIXs could coexist on one single viral particle.
Since a Flag tag is also present at the N terminus of mRFP1 protein, we
cannot exclude the possibility that the all Flag epitopes detected in EM
experiments came from IX-mRFP1 protein in the double and triple pIX-
modiﬁed viruses. Nonetheless, this possibility is very rare because
incorporation rate of IX-Flag protein was much higher than that of IX-
mRFP1 protein as shown in Western blotting of viral particles.
Generation of triple mosaic Ad by co-infection
A co-infection strategy has been employed by Takayama et al.
(2003) in generating mosaic Ad, in which two Ad genomes containing
distinct serotypes of ﬁber were co-transferred into 293 cells. In this
situation, both ﬁbers were expressed in 293 cells and assembled into
virion at random, resulting in ﬁber mosaic Ad. We therefore utilized
this strategy as an alternative method to prove the principle of triple
mosaicism on pIX. By co-infecting 293 cells with Ad5IXFlag, Ad5IXHis6
and Ad5IXmRFP1, each of which contains a single type of modiﬁed
pIX, three IX–ligand fusion proteins were expressed for the production
of viral progenies. The results showed that all kinds of double and
triple pIX mosaic Ads were successfully generated by co-infecting 293
cells with Ad5IXFlag, Ad5IXHis6 and Ad5IXmRFP1 in corresponding
combinations (Fig. 8), indicating that pIX mosaicism is a realizable
feature of Ad and co-infection strategy is also an effective and efﬁcient
to generate pIX mosaic virus.
Discussion
Adenovirus based viral vector has been utilized in a large number of
gene therapy studies via a variety of modiﬁcations. Recent evidences
suggested that incorporation of functional motifs into Ad capsid has
several advantages over conventional gene therapy strategies which
express transgenes after infection. For examples, with regard to viral
vector imaging, the expression of reporter genes can only provide
indirect information of virus localization and replication, which is
determined by transcriptional and translational activity of that par-
ticular transgene in the target cells, and possibly cause non-speciﬁc
expression in non-target cells. However, if linked on Ad capsid,
polypeptides function directly after viral infection with no need of
expression. This property is especially important for transducing cer-
tain cell types where promoter activity is low. This thought was
explored in the study of monitoring oncolytic adenoviruses in vivo (Le
et al., 2006), where the physical trafﬁcking and distribution of Adwere
under observationwith an imaging modality incorporated on pIX. The
C terminus of pIX was suggested to be a potential local to incorporate
functional modalities in several studies. Besides the imaging motif
(Le et al., 2006), thymidine kinase can also be incorporated in this
locale with its native function maintained (Li et al., 2005), suggesting
Ad vector's potentials in oncolysis and cancer therapy. Previous stud-
ies (Campos and Barry, 2006; Kurachi et al., 2007) suggested that
transductional targeting via incorporating targeting ligand on the
C terminus of pIX usually is not as effective as doing thus on ﬁber knob,
partially due to its relatively low accessibility by virtue of the topology
and dimensional arrangement of pIX proteins within GONs and steric
hindrance effect from ﬁbers. This issue may be circumvented by lifting
Fig. 7. Immuno-gold electron Microscopy on pIX-modiﬁed Ads. Viruses were loaded onto EM grids, probed with gold nanoparticle conjugated antibodies, and observed under
electron microscope at 60 kV. (A) Ad5; (B) Ad5IXFlag; (C) Ad5IXHis6; (D) Ad5IXmRFP1; (E) Ad5-IXFlag-IXmRFP1 and (F) Ad5-IXFlag-IXHis6-IXmRFP1. Primary and gold-conjugated
secondary antibodies employed were following: mouse anti-Flag, goat anti-His6, and rabbit anti-RFP primary antibodies were used for detecting 3 epitopes; 10 nm gold-donkey anti-
mouse, 18 nm gold-donkey anti-goat, and 25 nm gold-donkey anti-rabbit secondary antibodies for gold labeling. Solid thin arrows point 10 nm gold particles, empty arrows point
18 nm gold particles and solid thick arrows point 25 nm gold particles. Scale bars in each panel represent 50 nm in length.
Fig. 8. Generation of pIX mosaic Ad5 by co-infection. 293 cells were co-infected with pIX-modiﬁed Ads (each virus carries one type of pIX) in the following combination at MOI of 20
VP/cell: A, Ad5IXFlag and Ad5IXHis6; B, Ad5IXFlag and Ad5IXmRFP1; C, Ad5IXHis6 and Ad5IXmRFP1; D and E, Ad5IXFlag, Ad5IXHis6 and Ad5IXmRFP1. CsCl-puriﬁed viral particles
were stained with corresponding primary and gold-conjugated secondary antibodies as following: mouse anti-Flag, goat anti-His6, and rabbit anti-RFP primary antibodies were used
for detecting 3 epitopes; 10 nm gold-donkey anti-mouse, 18 nm gold-donkey anti-goat, and 25 nm gold-donkey anti-rabbit secondary antibodies were used for gold labeling. Solid
thin arrows point 10 nm gold particles, empty arrows point 18 nm gold particles and solid thick arrows point 25 nm gold particles. Scale bars in each panel represent 50 nm in length.
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397Y. Tang et al. / Virology 377 (2008) 391–400the targeting ligand toward the hexon top via alpha-helical spacers to
improve accessibility as illustrated by Vellinga et al. (2004), although
this hypothesis is under debate (Campos and Barry, 2006; Kurachi
et al., 2007). In addition, better understanding of organ and tissue's
physical barriers makes it possible to deliver viral vectors in vivomore
efﬁciently than before by utilizing various transcytosis machineries
(Bobardt et al., 2007; Bomsel, 1997; Di Pasquale and Chiorini, 2006;
Tang et al., 2007; Zhu et al., 2004), which needs an extra relayingmotif
for transcytosis besides the targeting ligand against the receptor of
destination. On the other hand, development of viral vectors may also
be favored in terms of efﬁcacy and reliability by therapeutic synergism
and imaging redundancy, both of which need more than one in-
corporation site to accommodate the synergistically therapeuticmotifs
or an extra imaging motif on the viral capsid.
In this proof-of-principle study, we explored the possibility of
incorporating three different pIX proteins into a single Ad5 virion
capsid by replacing the native pIX gene with three expression cas-
settes encoding three modiﬁed pIX proteins containing Flag, His6
polypeptides or mRFP1 protein at the C terminus, respectively. The Ad
containing double or triple pIX modiﬁcations, Ad5-IXFlag-IXmRFP1
and Ad5-IXFlag-IXHis6-IXmRFP1, were successfully rescued. The three
modiﬁed pIXs were incorporated into viral capsid and accessible to
antibodies. By labeling pIX-modiﬁed viruses with three tag-speciﬁc
antibodies which were conjugated with gold nanoparticles in three
different sizes, we have showed that two or three heterologous IX
proteins could coexist on a single virion of Ad5-IXFlag-IXmRFP1 or
Ad5-IXFlag-IXHis6-IXmRFP1, respectively.
However, pIX-modiﬁed Ads appeared be more thermolabile than
control Ad5 as shown in the heat inactivation assay (Figs. 6A and B),
which is not unexpected sincepIXplays an important role inAd stability.
Of note, Ad5-IXFlag-IXHis6-IXmRFP1 seems to be more thermostable
than AdIXmRFP1 and Ad-IXFlag-IXmRFP1. This can be explained by
that the capsid of triple pIX-modiﬁed viruses containsmore IX-Flag and
IX-His6 proteins, which are small in size and do not affect the cement
function of pIX and overall stability of Ad5 virion (Dmitriev et al., 2002).
In thegrowth kinetics experiment (Fig. 6C), the functionalmultiplicity of
control Ad5, Ad5IXmRFP1, Ad5-IXFlag-IXmRFP1, Ad5-IXFlag-IXHis6-
IXmRFP1 were 0.050, 0.013, 0.013, 0.020 PFU/cell, respectively. Thus,
the 2-log difference of recovered viral progenies after 24 h between
control Ad5 and pIX-modiﬁed virus could hardly be explained by
different initial infection. This, together with the delayed full CPE for-
mation in pIX-modiﬁed viruses, suggested that modiﬁcation on pIX had
adverse effect on viral replication and/or assembly. These data was
consistent with previous studies, in which deletion, mutation and mo-
diﬁcation of pIX was suggested to perturb Ad's stability (Colby and
Shenk, 1981; Dmitriev et al., 2002; Ghosh-Choudhury et al., 1987; Rosa-
Calatrava et al., 2001; Vellinga et al., 2005). In particular, pIX whole
protein was essential for genome packaging and stability, and resi-
dues 13–15 and 22–28 at the N terminus were vital since deletion of
these residues made viruses seriously thermolabile. The central region
andC-terminal domains seemed tobe trivial in this regard becausepoint
mutations (L114P and V117D) and deletions on residues 60–72 (alanine
stretch)/100–114 (large part of leucine repeat) neither caused problems
in pIX incorporation nor viral thermolability, arguing for a good
tolerance of modiﬁcation in these two regions. However, the properties
of heterologous peptideper se, such as structure, size and electric charge,
may affect the stability (Dmitriev et al., 2002). In addition, pIX was
suggested to be involved in virus-induced nuclear reorganization and
inhibiting cellular antiviral responses (Rosa-Calatrava et al., 2001; Rosa-
Calatrava et al., 2003), and act as a transcriptional activator (Lutz et al.,
1997), although the signiﬁcance is under controversy (Sargent et al.,
2004). Therefore, structural compromise on leucine repeat at the
C terminus and alanine stretch at the central region of pIXmay also be a
cause of the delayed CPE induction by pIX-modiﬁed Ads.
Three heterologous pIXs were incorporated into viral capsid as
revealed by western blotting analysis on lysed viral protein as wellas ﬂuorescence microscopy, ELISAs, and immunogold EM on puriﬁed
viral particles. Nevertheless, these data also suggested that three types
of pIX were not equally incorporated. In Western blotting analysis, IX-
Flag protein appeared to be the most and IX-mRFP1 seemed to be the
least. Fluorescence microscopy, ELISA and immunogold EM also sug-
gested possible low incorporation rate of IX-mRFP1 protein. The
unequivalent stoichiometry of IX proteins could be by virtue of their
synthesis since three modiﬁed pIX genes were driven by three dif-
ferent promoters (CMV, SV40, and pIX native promoter). These three
promoters apparently had different activity since protein expression
of modiﬁed pIXs in Ad infected cells were quite different both in time
and strength (data not shown). In addition, the properties of modiﬁed
pIX such as size, charge and conformation could also cause aggrega-
tion and incompatibility, and interfere with viral assembly (Ugai et al.,
unpublished data).
By labeling the three types of pIXs with gold nanoparticles in three
different sizes, EM provided a direct evidence of the coexistence of
heterologous IX–ligand fusion proteins in viral capsid, and further
demonstrated that the triple mosaicism could be the feature of a
single virion rather thanmixed viral populations. It is noteworthy that,
although there are 240 copies of pIX molecules in each viral particle,
only a few gold nanoparticles were bound on Ad5-IXFlag-IXmRFP1
or Ad5-IXFlag-IXHis6-IXmRFP1 virus. This is probably due to spatial
hindrance effect of gold particles, and we chose big gold particles for
easier differentiation, which have relatively high spatial hindrance
effect against each other during staining. Besides, the low efﬁciency of
triple staining may be the reason of the scattered staining pattern
shown in the ﬁgure. Therefore, it is not unexpected that the frequency
of triply-labeled Ads is low that only about 2% viral particles were
positively stained with all three gold particles. Taken together, we
have demonstrated for the ﬁrst time a triple mosaic capsid conﬁg-
uration based on pIX modiﬁcation, and validated the possibility of
further radical engineering in pIX.
Materials and methods
Antibodies
The pIX-speciﬁc antibody was a kind gift fromDr. I. Dmitriev (Gene
Therapy Center, University of Alabama at Birmingham). The mouse
anti-His6 monoclonal antibody was purchased from Qiagen (Valencia,
CA.). The goat polyclonal anti-His6 antibody was purchased from
Abcam (Cambridge, MA.). The anti-Flag M2 monoclonal antibody was
purchased from Sigma (St. Louis, MO.). The rabbit polyclonal anti-RFP
antibody was purchased from Chemicon (Temecula, CA.). Horseradish
peroxidase (HRP)-conjugated goat anti-mouse and goat anti-rabbit
secondary antibodies, or alkaline phosphatase (AP)-conjugated goat
anti-mouse, goat anti-rabbit secondary antibodies, and electron
microscopy (EM) grade 18 nm colloidal gold-conjugated donkey
anti-goat were purchased from Jackson ImmunoResearch Laboratories
Inc. (West Grove, PA.). EM grade 10 nm gold-conjugated donkey anti-
mouse, EM grade 25 nm gold-conjugated donkey anti-rabbit second-
ary antibodies were purchased from Electron Microscopy Science
(EMS, Ft. Washington, PA.).
Cells
The human embryonic kidney cell line (293) transformed with
Ad5-E1 DNA, human lung carcinoma (A549) cells and human cer-
vix epithelial carcinoma cells (HeLa and GH329) were purchased
from American Type Culture Collection (ATCC, Manassas, VA.). All
cell lines were cultured in Dulbecco's modiﬁed Eagle medium-
Ham's F12 (50/50) medium (Sigma) containing 10% fetal calf serum
(HighClone, Logan, Utah), 2 mM L-glutamine, 100 U/ml of penicillin,
100 μg/ml of streptomycin, and grown at 37 °C in a 5% CO2 humi-
diﬁed incubator.
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The E1/E3 deleted Ad5 genome containing three modiﬁed pIX
genes were constructed as following sequentially:
(i) Generation of shuttle vector carrying two modiﬁed pIX genes,
pShuttle-IXFlag-IXmRFP1. The IX-Flag open reading frame (ORF)
was obtained by PCR on the template of a IX-Flag containing
shuttle plasmid named pShlpIXFlagNhel (Dmitriev et al., 2002),
using primers KpnI (s), 5′ - GC GGTACC ATGAGCACCAAC-
TCGTTTGATGGAAGC - 3′, and HindIII (as), 5′ - CCC AAGCTT CTAC-
CGCGCGCGCAAAACCCCTAA - 3′, with corresponding recognition
sequence underlined. Then the PCR product was digested and
cloned into pShuttle-CMV plasmid (Stratagene), resulting in
pShuttle-CMV-IX-Flag-pA. The expression cassette CMV-IX-Flag-
pA was ampliﬁed by PCR with primers NotI (5′), 5′ - GCAAGGGT
GCGGCCGC TAATAGTAATCAATTACGGGGTCAT TAG - 3′, and
SalI (3′), 5′ - GGCGC GTCGAC TAAGATACATTGATGAGTTTGGA-
CAAAC - 3′, and subcloned into pShuttle-IX-mRFP1 (Le et al.,
2006), resulting in a shuttle vector containing two modiﬁed pIX
genes: pShuttle-IXFlag-IXmRFP1.
(ii) Generation of the ﬁnal shuttle vector containing threemodiﬁed
pIX genes, pShuttle-IXFlag-IXHis6-IXmRFP1. To incorporate se-
quence encoding six consecutive histidines into the 3′ end of the
pIX gene (pIX-His6), two primers HindIII (5′), 5′ - CCC AAGCTT
ATGAGCACCAACTCGTTTGATGGAAGC - 3′, and XbaI-6H (3′), 5′ -
GC TCTAGA TTA GTG ATG GTG ATG GTG ATG AACCGCATT
GGGAGGGGAGGAAGC - 3′, were used with corresponding
recognition sites, stop codon and the sequence underlined, re-
spectively. The resultant PCR product was cloned into pGL3-
Control shuttle vector (Promega Corporation, Madison, WI)
containing simian virus 40 (SV40) early promoter using two-
enzyme digestion (HindIII and XbaI). The expression cassette
SV40-IX-His6-pA in pGL3-IX-His6 was excised by two-enzyme
digestion (SalI andXhoI), and cloned into SalI digested pShuttle-
IXFlag-IXmRFP1, resulting in ﬁnal shuttle vector containing 3
modiﬁed pIX genes, pShuttle-IXFlag-IXHis6-IXmRFP1.
(iii) Generation of pIX-modiﬁed adenoviral genomes by homologous
recombination in Escherichia coli (He et al., 1998). The shuttle
vector pShuttle-IXFlag-IXmRFP1 or pShuttle-IXFlag-IXHis6-
IXmRFP1 was linearized with PmeI restriction enzyme and
homologously recombined with pAdEasy-1 (Stratagene, La Jolla,
CA.) in electrocompetent BJ5183-Ad1 (Stratagene). The generated
adenoviral genomes contains two (IXFlag-IXmRFP1) or three
(IXFlag-IXHis6-IXmRFP1) modiﬁed pIX genes in E1 region. The
constructs of resultant Ad plasmids pAd5-IXFlag-IXmRFP1 and
pAd5-IXFlag-IXHis6-IXmRFP1 were conﬁrmed by restriction
digestions and sequencing.
Virus rescue, propagation and puriﬁcation
pAd5-IXFlag-IXmRFP1 and pAd5-IXFlag-IXHis6-IXmRFP1 were
linearized with PacI restriction enzyme; then the large fragments
(32.3 kb and 33.4 kb, respectively) were puriﬁed and tranfected into
293 cells grown in 25 cm2 ﬂasks with Superfect (Qiagen). The cells
were collected when evident cytopathic effect (CPE) were observed,
and disrupted by four freeze and thaw cycles. The lysates were cen-
trifuged at 3000 ×g for 5 min at 4 °C to move the cell debris. The
released viruses in the supernatantwere subsequently used for further
propagation until sufﬁcient 293 cells were infected (Nten 175 cm2
ﬂasks). The Ad in infected cells were puriﬁed essentially as described
previously (Wu et al., 2002). In brief, the cells were lysed by four freeze
and thaw cycles and centrifuged at 3800 ×g for 30 min at 4 °C to move
the cell debris. The cell extracts containing the viruses were loaded on
the top of a 1.33/1.45 CsCl step gradient and centrifuged at 55,000 ×g
for 3 h at 4 °C. Lower band containing infectious particles were re-centrifuged on another 1.33/1.45 CsCl step gradient at 100,000 ×g for
overnight at 4 °C. The resulting band of adenoviruseswas collected and
dialyzed four times against 500 ml phosphate buffered saline (PBS)
containing 10% glycerol, 2 h each time. The generated Ads were
designated as Ad5-IXFlag-IXmRFP1 (containing two types of pIX)
and Ad5-IXFlag-IXHis6-IXmRFP1 (containing three types of pIX). Viral
particle titers were determined by spectrophotometry at OD260
(Maizel et al., 1968).
Protein electrophoresis and Western blotting
Puriﬁed viruses were boiled in Laemmli sample buffer for 5 min
and separated on 4 to 15% gradient sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE). Separated proteins were
then transferred to polyvinylidene diﬂuoride (PVDF) membranes,
which were blocked in 5% milk in Tris-buffered saline containing
0.05% Tween-20 followed by primary antibodies incubation (rabbit
anti-pIX, 1:1000; mouse anti-Flag, 1:1000; mouse anti-His6, 1:1000;
rabbit anti-RFP, 1:1000). After washing and re-blocking, the mem-
brane was incubated with corresponding secondary antibodies
conjugated to HRP or AP at 1:1000 dilution. The HRP signal was de-
veloped with ECL plus Western blotting detection system (GE health-
care, Little Chalfont, UK), detected with BioMax MR scientiﬁc imaging
ﬁlm (Kodak, Chalon-sur-Saone, France) and medical ﬁlm processor
SRX-101A (Konica, Tokyo, Japan). AP signal was developed with AP
staining solution containing 5-bromo-4-chloro-3-indolylphosphate
(BCIP)/nitro blue tetrazolium (NBT) according to the manufactory
protocol (Sigma).
ELISA
Solid-phase binding enzyme-linked immunosorbent assays (ELI-
SAs) were performed essentially as described previously (Wu et al.,
2005). Brieﬂy,109 VP viruseswere subjected to serial dilution (1, 2, 4, 8,
16, 32, 64, 128) in 100 μl of 100 mM carbonate buffer (pH 9.5), and
immobilized triplicately in a 96-well plate (Nunc Maxisorp) by over-
night incubation in at 4 °C. After 4washeswith 0.05% Tween 20 inTris-
buffered saline (TBS-T) and blocking with TBS-T containing 2% bovine
serum albumin (BSA), the viruses were probed with primary antibody,
and then AP-conjugated secondary antibodies in TBS-Tcontaining 0.5%
BSA at room temperature for 2 h, with extensive washes and blocking
in between. p-nitrophenyl phosphate (Sigma) was used for color
development as described by the manufacturer, and light absorbance
(405 nm) was obtained by a microplate reader (PowerWave HT 340,
BioTek, Winooski, VT.) after incubation for 90 min.
Fluorescence microscopy
Fluorescence microscopy on puriﬁed viral particles was performed
as following. 10 μl 50% glycerol/PBS solution containing 5×109 VPs of
viruses were dropped onto a Fisherﬁnest® premiummicroscope slides
(Fisher Scientiﬁc, Pittsburgh, PA.) and covered by Fisherband® #1
cover glass (Fisher Scientiﬁc). Fluorescence microscopy was per-
formed with an inverted IX-70 microscope (Olympus, Melville, NY)
equippedwith aMagniﬁre digital CCD camera (Optronics, Goleta, CA.).
Quantitative polymerase chain reaction (Q-PCR)
For quantiﬁcation of adenoviral E4 DNA, TaqManprimers and probes
were designed by the Primer Express 1.5 software and synthesized by
SigmaGenosys (Woodlands, Texas). The sequences of primers andprobe
to amplify E4 gene were following: forward primer 5′ - GGAGTGCGCC-
GAGACAAC - 3′, reverse primer 5′ - ACTACGTCCGGCGTTCCAT - 3′ and
probe 6FAM- TGGCATGACACTACGACCAACACGATCT - TAMRA. With
optimized concentration of primers and probe, the components of
Real-Time PCR mixture were designed to result in a master mix with a
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(Applied Biosystems, Foster City, CA.), 100 nM forward primer, 100 nM
reverse primer, 100 nM probe and 0.025% BSA. For the assay, known
amount of E4 template DNA (108, 106, 104 and 102 copies/μl) was
ampliﬁed to generate a standard curve for quantiﬁcation of the E4 copy
numbers of samples. 1 μl of sample was added to 9 μl of PCR mixture in
each reaction capillary. Two no-template-control capillaries received
1 μl of water. All capillaries were then sealed and centrifuged using LC
Carousel centrifuge (RocheMolecular Biochemicals, Indianapolis, IN.) to
facilitate mixing. PCR was carried out using a LightCycler™ system
(Roche Molecular Biochemicals). Thermal cycling conditions were
following: 10 min at 95 °C and 40 cycles of 15 s at 95 °C and 1 min at
60 °C. Data was analyzed with LightCycler software 3.
CAR binding inhibition assay
293 cells were plated in 48-well plates at a density of 6×104 cells
per well the day before binding, on which viral particles equivalent to
anMOI of 1000 were used for binding assay. Virus were pre-incubated
with sCAR (200 μg/ml) protein in DMEM/F12 medium containing 2%
FBS at room temperature for 10 min, and then were incubated with
cells at 4 °C. After 2 h, cells were washed with cold PBS, harvested by
Versene/EDTA. Total DNA was extracted from collected cells using
QIAamp DNA Blood mini kit (Qiagen) and subjected to Q-PCR to
measure Ad5 E4 copy numbers.
Genome transfer assay
293, A549, GH329 or HeLa cells were plated in 12-well plates at a
density of 3×105 cells per well the day before infection. Viral particles
equivalent to anMOI of 100were used for each infection in DMEM/F12
medium containing 2% FBS at 37 °C. After 2 h, the infected cells were
washed by PBS and harvested by Trypsin/EDTA. Total DNA was
extracted from collected cells by using QIAamp DNA Blood mini kit
(Qiagen) and subjected to Q-PCR to measure Ad5 E4 copy numbers.
Heat inactivation assay
Heat inactivation assay was performed essentially as described
previously (Dmitriev et al., 2002; Wu et al., 2002, 2005). Brieﬂy, viruses
were incubated at 45 °C for 0, 5, 10, 20 or 40 min in either PBS (without
Ca2+ and Mg2+) or growth medium containing 2% FBS. Then their
infectious titers were re-determined by standard Tissue Culture Infec-
tious Dose 50 (TCID50) method (AdEasy vector system, Qbiogene,
Carlsbad, CA). In brief, 100 μl growth medium containing 2% FBS and
104 293 cellswere addedon two96-wellﬂatbottomplates thedaybefore
infection. Eight serial dilutions of the virus ranging from 10−3 to 10−10
were made in medium containing 2% FBS, and 100 μl of diluted viruses
were added into 96-well plates, one row for each dilution. After incu-
bation for 10days at 37 °C in5%CO2humidiﬁed incubator, theplateswere
examined for CPE under microscope. Observable CPE containing wells
were counted for each row in order to determine the ratio of positive
wells per row in the 96-well plates. Titerwas calculated byusing KARBER
statistical method: T (TCID50 titer)=10×101+d(S−0.5)/ml, in which d is the
log 10 of the dilution and S is the sum of ratios from the ﬁrst dilution.
Statistical analysis
Statistical analysis was performed with two-tailed unpaired Stu-
dent's t-tests among groups. P values b0.05were considered statistically
signiﬁcant.
Growth kinetics
Growth kinetics of adenovirus was obtained essentially as des-
cribed previously (Wu et al., 2002). 293 cells were plated in 6-wellplates at the density of 3×105 cells per well 24 h before infection. The
cells were infected with adenoviruses at an MOI of 5 VPs/cell in 500 μl
growth medium containing 2% FBS. 1.5 ml more growth medium
containing 10% FBS was then added into each well after 2 h incubation
at 37 °C in 5% CO2 humidiﬁed incubator. The infected cells were
monitored and harvested with medium at various time point post
infection until complete CPE was formed. The collected cells together
with the medium were lysed by four cycles of freeze–thaw in dry ice
and water bath, and were subjected to centrifugation at 3000 ×g for
30 min at 4 °C for cell debris removal. The total viruses in each well
were determined by multiplying TCID50 titer with the total volume of
the supernatant, and plotted on the diagram as growth curves.
Immunoelectron microscopy
Viruses were ﬁxed with 2% paraformaldehyde/PBS at room
temperature for 10 min and adhered to 400-mesh nickel grids sup-
ported with carbon-coated Formvar ﬁlm (EMS). After washingwith 1%
BSA/PBS twice for 10 min each, grids were probed with 1% BSA/PBS
diluted primary antibodies (1:200 for goat anti-His6, M2 anti-Flag and
rabbit anti-RFP) and incubated at room temperature for 1 h. After 2
cycles of 1%BSA/PBS washes, grids were incubated with 1:40 diluted
secondary antibodies (10 nm gold-donkey anti-mouse, 18 nm gold-
donkey anti-goat, and 25 nm gold-donkey anti-rabbit) at room
temperature for 30 min. After ﬁxing with 1% glutaraldehyde/PBS for
20 min, grids were subjected to negative staining in 2% uranyl acetate
for 12 s and examined under transmission electron microscope in UAB
High Resolution Imaging Facility.
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